<!DOCTYPE html>
<html>
<head>
  <title>Roshan Lodha CV</title>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="stylesheet" href="./assets/cv.css">
</head>
<body>
  <header>
    <h1>Roshan Lodha</h1>
    <p>
      <a href="mailto:lodhar@ccf.org">lodhar@ccf.org</a> | <a href="tel:510-779-8518">(510) 779-8518</a> | <a href="https://github.com/roshanlodha">github.com/roshanlodha</a>
    </p>
  </header>
  <main>
    <section>
      <h2>Education</h2>
      <hr>
      <ul>
        <li>Doctor of Medicine, <i>Cleveland Clinic Lerner College of Medicine, 2026</i></li>
        <li>Master of Science in Biomedical Engineering, <i>Case Western Reserve University, 2026</i></li>
        <li>Bachelor of Arts in Computer Science, <i>University of California - Berkeley, 2021</i></li>
        <li>Bachelor of Arts in Biochemistry & Molecular Biology, <i>University of California - Berkeley, 2021</i></li>
      </ul>
    </section>
    <section>
      <h2>Research Experience and Projects</h2>
      <hr>
      <h3><a href="https://github.com/roshanlodha/radiogenomics">Computational Cardiology - Chung Lab, Cleveland Clinic Foundation</a></h3>
      <p>Mina Chung, M.D. and John Barnard, Ph.D., <i>2021-present</i></p>
      <ul>
        <li>Developed and implemented machine learning models for identifying and categorizing cardiac arrhythmias.</li>
        <li>Investigated the potential applications of quantum computing algorithms in arrhythmia detection.</li>
        <li>Collaborated with clinical and computational researchers to analyze and interpret patient data.</li>
      </ul>
      <h3><a href="https://github.com/roshanlodha/bevacizumab-response">Bioinformatic Neuro-oncology - Gladson Lab, Lerner Research Institute</a></h3>
      <p>Candece Gladson, M.D., <i>2021-present</i></p>
      <ul>
        <li>Designed and optimized an RNA-sequencing pipeline for analyzing the molecular characteristics of glioblastomas.</li>
        <li>Conducted bioinformatic analyses to identify differentially expressed genes and signaling pathways associated with bevacizumab resistance.</li>
        <li>Contributed to the interpretation and presentation of the data in manuscripts and conference presentations.</li>
      </ul>
      <h3><a href="https://github.com/roshanlodha/NRMA">Non-random Rotation Matching Algorithm (NRMA)</a></h3>
      <p>Craig Nielsen, M.D., <i>2023</i></p>
      <ul>
        <li>Developed NRMA, a non-random rotation matching algorithm for medical students, utilizing linear sum optimization techniques to match students with their rotation preferences.</li>
        <li>Implemented and tested the algorithm to ensure efficient and accurate matching, resulting in improved student satisfaction and reduced administrative burden.</li>
        <li>Collaborated with medical faculty and staff to gather rotation preference data, incorporate feedback, and continuously improve the algorithm over multiple iterations.</li>
      </ul>
      <h3>Biochemical Oncology - Feng Lab, University of California, San Fransisco</h3>
      <p>Jonathan Chou, M.D., Ph.D., <i>2018-2021</i></p>
      <ul>
        <li>Conducted experiments using cell culture and animal models to investigate the effects of CDK12 inhibition on prostate cancer progression.</li>
        <li>Developed and executed bioinformatics analyses of transcriptomic and genomic data to identify potential targets for therapeutic intervention.</li>
      </ul>
    </section>
    <section>
      <h2>Publications and Presentations</h2>
      <hr>
        <b>Tumors that respond poorly to bevacizumab therapy show upregulation of angiogenesis gene sets.</b>
        <br><i>Roshan Lodha, Gaelle Muller-Greven, Lydia Guo, and Candece L. Gladson</i>
        <br>Poster Presentation - American Association for Cancer Research, 2023
        <br>
        <br>
        <b>Characterizing immune-genomic signatures associated with response to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC).</b>
        <br><i>Nikhil Pramod, Paul Pavicic, Scott Dawsey, Roshan Lodha, Ubenthira Patgunarajah, Moshe Ornstein, Timothy Gilligan, Christopher Wee, Omar Mian, Amanda Nizam, Jane Nguyen, Claudia Marcela-Diaz, Shilpa Gupta</i>
        <br>Poster Presentation - American Society of Clinical Oncology, 2023
        <br>
        <br>
        <b>Germline variant positive melanoma patients exhibit an enhanced inflammatory microenvironment.</b>
        <br><i>Alan Shen, Roshan Lodha, Brandon Bungo, Michelle Arbesman, Nikhil Pramod, Jennifer Ko, Brian Gastman, C. Marcela Diaz, Timothy Chan, Joshua Arbesman, Pauline Funchain</i>
        <br>Poster Presentation - American Association for Cancer Research, 2023
        <br>
        <br>
        <b>Recurrence free survival (RFS) to adjuvant checkpoint immunotherapy (IO) is improved amongst germline pathogenic variant (gPV) positive patients with melanoma.</b>
        <br><i>Alan Shen, Michelle Arbesman, Roshan Lodha, Nicole Buturla, C. Marcela Diaz, Pauline Funchain, Joshua Arbesman</i>
        <br>Poster Presentation - International Societies of Investigative Dermatology, 2023
    </section>
    <section>
      <h2>Awards and Honors</h2>
      <hr>
      <ul>
        <li><b>Full Tuition Scholarship</b>, Cleveland Clinic Lerner College of Medicine, <i>2021-2026</i></li>
        <li><b>Third Place Poster Presentation</b>, Association of Indian Physicians of Northern Ohio, <i>2022</i></li>
        <li><b>Honors in Molecular & Cell Biology</b>, University of California - Berkeley, <i>2021</i></li>
      </ul>
    </section>
    <section>
      <h2>Organizations and Leadership</h2>
      <hr>
      <ul>
        <li>Co-president - Oncology Student Interest Group of CCLCM, <i>2021-2023</i></li>
        <li>Co-president - Medical Reallocation Initiative of CWRU SOM, <i>2021-2023</i></li>
        <li>Co-president - CaseMed Tech, <i>2022-2023</i></li>
      </ul>
    </section>
  </main>
</body>
</html>
